Parenteral delivery routes intranasal administration

The success of vaccination depends primarily on the method of presenting the antigen to the host immune system. Antigens have usually been delivered by parenteral (such as intravenous, intramuscular, intraperito-neal, intradermal, and subcutaneous) administration, but recent studies have shown that other routes of delivery such as intranasal, oral, and transdermal delivery have also been effective. In some cases, vaccination through mucosal routes resulted in better responses in IgA production. Because non-parenteral vaccine delivery presents many obvious advantages, numerous attempts have been made on the development of non-parenteral delivery of vaccines. 

Multiple emulsions have been widely studied as means of delivering drugs via oral, topical, and parenteral routes. The applications include protein delivery (Cournarie et al., 2004), delivery of antibiotics to the vagina (Tedajo et al., 2005), sustained delivery (Vaziri and Warburton, 1994), and vaccine delivery (Bozkir and Hayta, 2004). The immunological response to a vaccine also depends on the route of administration. Most current vaccines are administered intramuscularly, which induces immunization as a systemic immunity. However, the live polio vaccine and the live typhoid vaccine are administered orally. Local immunization (oral, intranasal, or intravagina) may be preferred, since mucosal surfaces are the common entrance to many pathogens. Moreover local immunization induces both mucosal and systemic immunity. Ease of administration and avoidance of systemic side effects are additional advantages of local immunization (Walker, 1994 Shalaby, 1995). Nevertheless, successful local immunization has only been achieved with a limited number of oral vaccines. Also there are very few studies on multiple emulsions used in the immunization process, especially on parenteral and oral administration. 

The ability to assemble self-adjuvanting immunogens obviates the need for emulsification in traditional and often harmful oil based adjuvants and also allows different delivery routes to be accessed. The PamSCys peptide was equally effective when delivered by the intranasal route as when delivered parenterally (Fig.6). Furthermore, the PamSCys-peptide elicited IgA antibody forming cells in the lung and draining lymph nodes following intra-nasal administration. Clearly the ability to induce IgA has ramifications for vaccines that are required to induce mucosal immune responses such as those to prevent respiratory diseases as well as HIV and other sexually transmitted pathogens. The ability to deliver vaccines... 

---